A share price of Inmode Ltd [INMD] is currently trading at $22.94, down -1.21%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INMD shares have gain 4.32% over the last week, with a monthly amount drifted -4.42%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 4, March 2024, InMode to Present at March Investor Conferences and Events. In a post published today on Yahoo Finance, InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in March:.
From an analyst’s perspective:
Inmode Ltd [NASDAQ: INMD] stock has seen the most recent analyst activity on November 03, 2023, when UBS downgraded its rating to a Neutral and also revised its price target to $24 from $52. Previously, Canaccord Genuity downgraded its rating to Hold on October 13, 2023, and dropped its price target to $22. On March 29, 2023, UBS initiated with a Buy rating and assigned a price target of $40 on the stock. Needham downgraded its rating to a Hold. Barclays initiated its recommendation with a Overweight and recommended $44 as its price target on December 21, 2022. Jefferies started tracking with a Buy rating for this stock on October 12, 2022, and assigned it a price target of $40. In a note dated May 25, 2021, Barclays initiated an Overweight rating and provided a target price of $92 on this stock.
Inmode Ltd experienced fluctuations in its stock price throughout the past year between $18.57 and $48.25. Currently, Wall Street analysts expect the stock to reach $53.5 within the next 12 months. Inmode Ltd [NASDAQ: INMD] shares were valued at $22.94 at the most recent close of the market. An investor can expect a potential return of 133.22% based on the average INMD price forecast.
Analyzing the INMD fundamentals
Trailing Twelve Months sales for Inmode Ltd [NASDAQ:INMD] were 492.05M which represents -5.08% decline. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.4%, Pretax Profit Margin comes in at 0.44%, and Net Profit Margin reading is 0.4%. To continue investigating profitability, this company’s Return on Assets is posted at 0.23, Equity is 0.28 and Total Capital is 0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.73 points at the first support level, and at 22.51 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.18, and for the 2nd resistance point, it is at 23.41.
Inmode Ltd [INMD] reported earnings per share of $0.71 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.67/share, meaning a difference of $0.04 and a surprise factor of 6.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.61 per share as compared to estimates of $0.64 per share, a difference of -$0.03 representing a surprise of -4.70%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Inmode Ltd [NASDAQ:INMD] is 13.18. Further, the Quick Ratio stands at 12.29, while the Cash Ratio is 2.25. Considering the valuation of this stock, the price to sales ratio is 3.93, the price to book ratio is 2.45 and price to earnings (TTM) ratio is 9.94.
